Your search matched 411 results
Live From Lions Health: Facebook announced key new ways its serving the pharma industry, including new services and policy exemptions.
“The doctor will see you now” has traditionally been followed by a walk down an antiseptic-smelling hallway, with a quick stop at the scale on your way to the paper gown.
Your patient may also like… | Blog
Live from Cannes Lions Health: The history of healthcare communications is full of directives about what we should do or even have to do.
The Ultimate Creative Act | Blog
Live from Cannes Lions Health: The first day of Cannes Lions kicked off with a quote from the famous Bill Bernbach: “All of us who professionally use the mass media are the shapers of society.
Nobody wants their doctor to say, “you’re losing your hearing,” but for the 48 million Americans suffering from hearing loss, most dread the idea of the clunky, uncomfortable hearing aids of yester-year.
Live from eyeforpharma Philadelphia 2019— why pharma needs to defy conventions in problem solving in order to drive change and impact.
A recent proposal by the U.S.
Pharmaceutical giant Roche’s new app for people with multiple sclerosis (MS) revolutionizes how doctors care for patients with the disease.
Live From Lions Health: A bracelet that changed the way families think about vaccines, a playroom for kids that’s a workout for parents, a nutrition-Rx from a railroad, and AI that’s prompting better in-train-station nutrition for busy commuters.
Why is it that pharma apps don’t get the same downloads and usage as apps from other industries?
When it comes to food, our stomachs may know very well when they’re full, but the brain has veto power.
Nonprofit hospital system Partners HealthCare has unveiled a joint venture with Circulation, an on-demand rideshare service, through which Medicare patients receive free rides to their doctor’s offices in non-emergencies.
As with any new pharma launch, much planning goes into messaging, target market, channel optimization, and several additional pieces to the process.
Lilly & Harvard Pilgrim Healthcare's CEOs shared their thoughts on value-based arrangements between pharma and payers
The American Medical Association (AMA) released new numbers from a study that revealed that doctors that had an ownership stake in their practice no longer make up the majority of the nation’s patient care physicians.
Takeda: #FlyWithIBD | Blog
After a recent unpleasant transcontinental flight due to IBD, a Takeda employee was left with one question, “How can the company I work for help people flying with IBD have a more comfortable flight experience?”
Sukh Chugh, Director of Research and Development Informatics Services (RDIS) at Allergan, stepped up to the Digital Pharma West podium to talk about managing global teams as one of the last talks of the day.
I went to the movies the other day and I was greeted at the ticket counter to discover that I had my own assigned seat.
You’ve heard of the genius bar concept.
Fabrizio Caranci, Director of Channel Innovation at Merck, started out with this super fact from John Chambers, CEO at Cisco: by 2020 over 30 billion objects will wirelessly be connected to the internet.
Eli Lilly plans to open a drug delivery and innovation center in Kendall Square, Massachusetts.
As the expectations of our modern patient (both young and old) continue to change, the market is being forced to make adaptations.
More and more we’re seeing hospitals champion innovation within their own walls.
Last month, The Journal of the American Heart Association published the results of a mHealth intervention study.
Betting on the Pharmacy | Blog
The transformation of the neighborhood pharmacy into an increasingly important and potent point of care has been written about extensively over the past few years.
Access for All | Blog
The National Federation for the Blind has filed a lawsuit against the US Department of Health and Human Services’ sub-agency, the Centers for Medicare and Medicaid Services (CMS), which is the largest single payor for health care in the United States.
Huntington’s disease is a rare, fatal neurodegenerative disease that is desperate for treatment options and doctors are doing their best to help improve the quality of life for the more than 30,000 people living with the disease and over 200,000 at-risk of inheriting it.
As patient centricity continues to become more of a focus for pharmaceutical companies and their brands, Novartis recently launched a dedicated social network for heart failure patients and caregivers called Together in HF.